AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Non Hodgkin Lymphoma
Clinical trial NCT03434769 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03434769
- Sponsor
- Benjamin Tomlinson
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-09
- Primary completion
- 2023-03-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.